Liraglutide add-on to metformin improves postprandial glucose control compared with metformin monotherapy in patients with Type 2 diabetes: posthoc analysis of the Liraglutide Effect and Action in Diabetes (LEAD)2 study

被引：0
|
作者：
Stephens, J. W. [1 ]
Fulcher, G. [2 ]
Matthews, D. R. [3 ]
Nauck, M. A. [4 ]
Svendsen, C. B. [5 ]
Donsmark, M. [5 ]
Garber, A. [6 ]
机构：
[1] Swansea Univ, Coll Med, Swansea, W Glam, Wales
[2] Northern Clin Sch, Sydney, NSW, Australia
[3] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England
[4] Diabeteszentrum, Bad Lauterberg im Harz, Germany
[5] Novo Nordisk AS, Med Affairs, Liraglutide Diabet, Soborg, Denmark
[6] Baylor Coll Med, Houston, TX 77030 USA
来源：
DIABETIC MEDICINE | 2014年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：178 / 178
页数：1
相关论文
共 50 条
  • [21] Treatment intensification with insulin degludec improves glycaemic control in patients with Type 2 diabetes treated with liraglutide and metformin
    Kumar, S.
    Aroda, V.
    Bailey, T.
    Cariou, B.
    Leiter, L.
    Raskin, P.
    Zacho, J.
    Philis-Tsimikas, A.
    DIABETIC MEDICINE, 2015, 32 : 66 - 66
  • [22] Cardiovascular Safety of Sodium Glucose Cotransporter 2 Inhibitors as Add-on to Metformin Monotherapy in Patients with Type 2 Diabetes Mellitus
    Jeon, Ja Young
    Ha, Kyoung Hwa
    Kim, Dae Jung
    DIABETES & METABOLISM JOURNAL, 2021, 45 (04) : 505 - 514
  • [23] Treat 4 Ramadan trial: a randomised control trial comparing liraglutide vs a sulphonylurea as add-on to metformin in patients with established type 2 diabetes
    Brady, E. M.
    Davies, M. J.
    Gray, L. J.
    Saeed, M. A.
    Hanif, W.
    Khunti, K.
    DIABETOLOGIA, 2013, 56 : S371 - S371
  • [24] Treat 4 Ramadan: A Randomised Control Trial Comparing Liraglutide vs. a Sulphonylurea as Add-On to Metformin in Patients With Established Type 2 Diabetes
    Davies, Melanie J.
    Brady, Emer M.
    Gray, Laura J.
    Saeed, Mujahid
    Wasim, Hanif
    Khunti, Kamlesh
    DIABETES, 2013, 62 : A661 - A661
  • [25] Saxagliptin improves glycaemic control either as add-on therapy to metformin or as initial combination therapy with metformin in patients with type 2 diabetes
    Pfuetzner, A.
    Gurieva, I
    Antsiferov, M.
    Allen, E.
    Ravichandran, S.
    Chen, R.
    SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 168S - 169S
  • [26] Saxagliptin improves glycaemic control either as add-on therapy to metformin or as initial combination therapy with metformin in patients with type 2 diabetes
    Gurieva, I.
    Pfuetzner, A.
    Antsiferov, M.
    Allen, E.
    Ravichandran, S.
    Chen, R.
    EUROPEAN HEART JOURNAL, 2009, 30 : 226 - 227
  • [27] Add-On Therapies to Metformin in Type 2 Diabetes: What Modulates the Respective Decrements in Postprandial and Basal Glucose?
    Monnier, Louis
    Colette, Claude
    Comenducci, Andrea
    Vallee, Denis
    Dejager, Sylvie
    DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 (10) : 943 - 950
  • [28] Liraglutide in Combination with Metformin or Sulfonylurea for the Treatment of Type 2 Diabetes in Adult Patients
    Udiawar, Maneesh V.
    Bain, Stephen C.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2012, 4 : 251 - 261
  • [29] Switching from Sitagliptin to Liraglutide, in Combination with Metformin, Improves Treatment Satisfaction in Patients with Type 2 Diabetes
    Montanya, Eduard
    Pratley, Richard
    Nauck, Michael
    Bailey, Timothy
    Garber, Alan
    Filetti, Sebastiano
    Thomsen, Anne B.
    Hammer, Mette
    Davies, Melanie
    DIABETES, 2011, 60 : A307 - A307
  • [30] Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
    Mendez-del Villar, Miriam
    Martinez-Abundis, Esperanza
    Preciado-Marquez, Rafael O.
    Gonzalez-Ortiz, Manuel
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2017, 61 (02): : 188 - 192
12345